CONMED CORP - NOTE 2.625% 2/0

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Debt / NOTE 2.625% 2/0
Market price (% of par)
122.69%
Total 13F principal
$69,695,000
Principal change
+$54,000
Total reported market value
$85,713,972
Number of holders
21
Value change
+$334,212
Number of buys
6
Number of sells
7

Institutional Holders of CONMED CORP - NOTE 2.625% 2/0 as of Q4 2023

As of 31 Dec 2023, CONMED CORP - NOTE 2.625% 2/0 was held by 21 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $69,695,000 in principal (par value) of the bond. The largest 10 bondholders included CAPSTONE INVESTMENT ADVISORS, LLC, WOLVERINE ASSET MANAGEMENT LLC, Warberg Asset Management LLC, JPMORGAN CHASE & CO, Elequin Capital, LP, ZAZOVE ASSOCIATES LLC, PALISADE CAPITAL MANAGEMENT, LP, WELLS FARGO & COMPANY/MN, WESTWOOD HOLDINGS GROUP INC, and CITIGROUP INC. This page lists 21 institutional bondholders reporting positions for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.